Dragica Milicevic, MD
Family Medicine · Springfield, ILNPI 1245344357
Payments from drug & device makers
Across 171 payments — averaging $34.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AstraZeneca$888
- Johnson & Johnson$720
- AbbVie$337
- Teva Pharmaceuticals USA, Inc.$307
- Madrigal Pharmaceuticals$292
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,90499%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $1,122 |
| AstraZeneca | 22 | $888 |
| Johnson & Johnson | 20 | $720 |
| AbbVie(2 entities) | 7 | $337 |
| Teva Pharmaceuticals USA, Inc. | 12 | $307 |
| Madrigal Pharmaceuticals | 2 | $292 |
| E.r. Squibb & Sons, L.L.C. | 3 | $281 |
| Abbott | 6 | $243 |
| Neurocrine Biosciences, Inc. | 2 | $233 |
| Novartis | 12 | $228 |
| GSK | 21 | $203 |
| Boehringer Ingelheim | 7 | $166 |
| Pfizer | 4 | $165 |
| Astellas Pharma US Inc | 2 | $161 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $120 |
| Bayer | 4 | $76 |
| Lilly USA, LLC | 4 | $74 |
| Novo Nordisk | 5 | $73 |
| Merck | 1 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Mylan Specialty L.p. | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,984 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $69,407 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $44,113 |
| FarxigaDapagliflozin Propanediol | 24 | $28,627 |
| MyrbetriqMirabegron | 23 | $18,499 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $17,814 |
| XareltoRivaroxaban | 12 | $16,981 |
| TrulicityDulaglutide | 18 | $15,771 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $11,074 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $8,953 |
| VascepaIcosapent Ethyl | 23 | $3,165 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $3,136 |
| Atorvastatin Calcium | 274 | $2,771 |
| Metoprolol Succinate | 228 | $2,654 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,300 |
| Omeprazole | 126 | $1,931 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $165 | $69,40779 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $203 | $53,06779 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $888 | $46,44145 claims |
| Astellas Pharma US IncMyrbetriq | $161 | $18,49923 claims |
| Johnson & JohnsonXarelto | $720 | $16,98112 claims |
| Lilly USA, LLCTrulicity | $74 | $15,77118 claims |
| Sanofi-aventis U.S. LLCLantus | $125 | $1,89412 claims |
| AbbVieSynthroid | $337 | $74511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Springfield
- Ali BajwaSpringfield$5.8M
- John WangSpringfield$114K
- Randy WesternSpringfield$28K
- Daniel BruneCreve Coeur$15M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.